Related references
Note: Only part of the references are listed.Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
Philipp Lohneis et al.
BRITISH JOURNAL OF CANCER (2018)
The Immune Revolution: A Case for Priming, Not Checkpoint
Robert H. Vonderheide
CANCER CELL (2018)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance
Martin Wartenberg et al.
CLINICAL CANCER RESEARCH (2018)
A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations
David Tamborero et al.
CLINICAL CANCER RESEARCH (2018)
Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas
Renato M. Lupinacci et al.
GASTROENTEROLOGY (2018)
Involvement of partial EMT in cancer progression
Masao Saitoh
JOURNAL OF BIOCHEMISTRY (2018)
MiR200 and miR302: Two Big Families Influencing Stem Cell Behavior
Francesca Balzano et al.
MOLECULES (2018)
Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
Chung-Han Lee et al.
TRENDS IN IMMUNOLOGY (2018)
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
Daniel J. McGrail et al.
NATURE COMMUNICATIONS (2018)
Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling
Erick Riquelme et al.
CANCER DISCOVERY (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype
Juliana B. Candido et al.
CELL REPORTS (2018)
Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
Aaron M. Goodman et al.
JAMA ONCOLOGY (2018)
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
Zhi Rong Qian et al.
JAMA ONCOLOGY (2018)
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Rikke B. Holmgaard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Targeting Epigenetic Aberrations in Pancreatic Cancer, a New Path to Improve Patient Outcomes?
Brooke D. Paradise et al.
CANCERS (2018)
Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy
Rille Pihlak et al.
CANCERS (2018)
Immune Evasion in Pancreatic Cancer: From Mechanisms to Therapy
Neus Martinez-Bosch et al.
CANCERS (2018)
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
Sebastian Mueller et al.
NATURE (2018)
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features
Francesco Puleo et al.
GASTROENTEROLOGY (2018)
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger et al.
NATURE REVIEWS CANCER (2018)
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
Linde De Smedt et al.
BRITISH JOURNAL OF CANCER (2017)
CD40-activated B cells induce anti-tumor immunity in vivo
Kerstin Wennhold et al.
ONCOTARGET (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
MicroRNA dysregulation in the tumor microenvironment influences the phenotype of pancreatic cancer
Eva Karamitopoulou et al.
MODERN PATHOLOGY (2017)
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran et al.
NATURE (2017)
MicroRNA-200b is downregulated in colon cancer budding cells
Kirsten Nguyen Knudsen et al.
PLOS ONE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
DNA profiling of tumor buds in colorectal cancer indicates that they have the same mutation profile as the tumor from which they derive
Irene Centeno et al.
VIRCHOWS ARCHIV (2017)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma
Ashton A. Connor et al.
JAMA ONCOLOGY (2017)
The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
Sunjida Ahmed et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
I. H. Sahin et al.
ANNALS OF ONCOLOGY (2017)
Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
A. Martinez-Marti et al.
ANNALS OF ONCOLOGY (2017)
Targeting the hepatocyte growth factor/Met pathway in cancer
Dinuka M. De Silva et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers
Erik S. Knudsen et al.
CLINICAL CANCER RESEARCH (2017)
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Giovanni Francesco Castino et al.
ONCOIMMUNOLOGY (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor
Shin Foong Ngiow et al.
CANCER RESEARCH (2016)
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
Bernhard Mlecnik et al.
IMMUNITY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer
Katelyn T. Byrne et al.
CELL REPORTS (2016)
Tumor Budding: The Name is EMT. Partial EMT.
Alexandru Dan Grigore et al.
JOURNAL OF CLINICAL MEDICINE (2016)
Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
Kate O'Connor et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer
J. A. Galvan et al.
BRITISH JOURNAL OF CANCER (2015)
Detailed analysis of epithelial-mesenchymal transition and tumor budding identifies predictors of long-term survival in pancreatic ductal adenocarcinoma
Ilona Kohler et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Manuel Hidalgo et al.
PANCREATOLOGY (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinoma
Martin Wartenberg et al.
ONCOTARGET (2015)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies
Jonathan Haqq et al.
EUROPEAN JOURNAL OF CANCER (2014)
MicroRNAs Cooperatively Inhibit a Network of Tumor Suppressor Genes to Promote Pancreatic Tumor Growth and Progression
Adam E. Frampton et al.
GASTROENTEROLOGY (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy
Eric R. Lutz et al.
ONCOIMMUNOLOGY (2014)
Tumour budding is a strong and independent prognostic factor in pancreatic cancer
E. Karamitopoulou et al.
EUROPEAN JOURNAL OF CANCER (2013)
Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
Abasi Ene-Obong et al.
GASTROENTEROLOGY (2013)
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene et al.
CANCER RESEARCH (2012)
Pancreatic stellate cells form a niche for cancer stem cells and promote their self-renewal and invasiveness
Enza Lonardo et al.
CELL CYCLE (2012)
Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Longterm Survivors
Shinichi Yachida et al.
CLINICAL CANCER RESEARCH (2012)
Network of WNT and Other Regulatory Signaling Cascades in Pluripotent Stem Cells and Cancer Stem Cells
Masaru Katoh
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations
S. Floor et al.
ONCOGENE (2011)
CD10+ Pancreatic Stellate Cells Enhance the Progression of Pancreatic Cancer
Naoki Ikenaga et al.
GASTROENTEROLOGY (2010)
EMT: When epithelial cells decide to become mesenchymal-like cells
Raghu Kalluri
JOURNAL OF CLINICAL INVESTIGATION (2009)
Share Paper
